Back to search
Elderly Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Elderly Infection trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Elderly Infection trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This prospective observational cohort study aims to investigate the relationship between immunosenescence and infectious diseases in older adults. Individuals a…
This is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study. The aim of this study is to dem…
This phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating patients with CD22-positive B-lineage acu…
The primary objective of this study is to conduct a 16-week randomized controlled trial aimed at investigating the effectiveness of the Whole-Diet Approach when…
Respiratory syncytial virus (RSV) is recognized worldwide as a significant pathogen causing lower respiratory tract infection in infants, the elderly, and immun…
This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymph…
Human papillomavirus (HPV) infection is the most common viral infection of the reproductive tract. Up to 80%of the sexually active females and men will be infec…
The purpose of this study is to learn about the effects of the study medicine called Paxlovid \[nirmatrelvir-ritonavir/PF-07321332\], for the potential treatmen…